Entropy Neurodynamics Limited has released a press release.
100% Clinical improvement, 50% Remission in BED study
Earlier from Entropy Neurodynamics
- DSMB Clears TRP 8803 to Advance to Cohort 2
- Entropy completes Cohort 1 dosing in BED trial
- Entropy files new US patent for IBS program